Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-04
DOI
10.1038/s41598-017-01942-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis
- (2016) Virender Kumar et al. BIOMATERIALS
- Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy
- (2016) Ekaterina Pak et al. DEVELOPMENTAL CELL
- Modeling the protonation states of β-secretase binding pocket by molecular dynamics simulations and docking studies
- (2016) Dima A. Sabbah et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Micelle Mixtures for Coadministration of Gemcitabine and GDC-0449 To Treat Pancreatic Cancer
- (2016) Melek Karaca et al. MOLECULAR PHARMACEUTICS
- Structural basis of Smoothened regulation by its extracellular domains
- (2016) Eamon F. X. Byrne et al. NATURE
- Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice
- (2016) Rinku Dutta et al. PHARMACEUTICAL RESEARCH
- AM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells
- (2016) Tomoyo Yoshinaga et al. PLoS One
- Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype
- (2016) Paola Infante et al. Cell Death & Disease
- Identification of Novel Smoothened Ligands Using Structure-Based Docking
- (2016) Celine Lacroix et al. PLoS One
- Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
- (2015) Scott X. Atwood et al. CANCER CELL
- Small molecules targeting microRNA for cancer therapy: Promises and obstacles
- (2015) Di Wen et al. JOURNAL OF CONTROLLED RELEASE
- Micellar formulation of indocyanine green for phototherapy of melanoma
- (2015) Vaibhav Mundra et al. JOURNAL OF CONTROLLED RELEASE
- Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer
- (2015) S.S. Islam et al. MOLECULAR CARCINOGENESIS
- Codelivery of Small Molecule Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer
- (2015) Virender Kumar et al. MOLECULAR PHARMACEUTICS
- Multisite interaction with Sufu regulates Ci/Gli activity through distinct mechanisms in Hh signal transduction
- (2015) Yuhong Han et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery and preclinical development of vismodegib
- (2014) Stephen E Gould et al. Expert Opinion on Drug Discovery
- Stromal response to Hedgehog signaling restrains pancreatic cancer progression
- (2014) J. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unraveling the therapeutic potential of the Hedgehog pathway in cancer
- (2013) Dereck Amakye et al. NATURE MEDICINE
- Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis
- (2013) Virender Kumar et al. PHARMACEUTICAL RESEARCH
- Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy
- (2013) R Hill et al. Cell Death & Disease
- Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma
- (2012) Anne Lynn S. Chang et al. ARCHIVES OF DERMATOLOGY
- RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells
- (2012) Jinghua Han et al. CANCER LETTERS
- Formulation and Characterization of Polyester/Polycarbonate Nanoparticles for Delivery of a Novel Microtubule Destabilizing Agent
- (2012) Vaibhav Mundra et al. PHARMACEUTICAL RESEARCH
- Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway
- (2012) Saurabh Singh et al. PLoS One
- Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells
- (2012) Kshama R. Jaiswal et al. Stem Cell Research
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition
- (2011) Sharmila Shankar et al. PLoS One
- Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms
- (2011) Brahma N. Singh et al. PLoS One
- Second generation 2-pyridyl biphenyl amide inhibitors of the hedgehog pathway
- (2010) Georgette M. Castanedo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
- (2010) Gerrit J. P. Dijkgraaf et al. CANCER RESEARCH
- Self-renewal mechanisms in neural cancer stem cells
- (2010) Theo Mantamadiotis Frontiers in Bioscience-Landmark
- Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
- (2010) Zeshaan A. Rasheed et al. JNCI-Journal of the National Cancer Institute
- Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist
- (2010) Shifeng Pan et al. ACS Medicinal Chemistry Letters
- Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-l-lactide) block copolymers for drug delivery
- (2009) Michael Danquah et al. BIOMATERIALS
- GDC-0449—A potent inhibitor of the hedgehog pathway
- (2009) Kirk D. Robarge et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells
- (2009) M. Santisteban et al. CANCER RESEARCH
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
- (2009) Charles M. Rudin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
- (2009) R. L. Yauch et al. SCIENCE
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Hedgehog Signaling in Development and Cancer
- (2008) Jin Jiang et al. DEVELOPMENTAL CELL
- Pancreatic Cancer Stem Cells
- (2008) Cheong J. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- 3-D Tumor Model forIn VitroEvaluation of Anticancer Drugs
- (2008) Jayme L. Horning et al. MOLECULAR PHARMACEUTICS
- ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells
- (2008) Julie Douville et al. STEM CELLS AND DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started